PE20090630A1 - Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion - Google Patents
Derivados de indol 2-carboxi sustituidos y metodos para su utilizacionInfo
- Publication number
- PE20090630A1 PE20090630A1 PE2008001453A PE2008001453A PE20090630A1 PE 20090630 A1 PE20090630 A1 PE 20090630A1 PE 2008001453 A PE2008001453 A PE 2008001453A PE 2008001453 A PE2008001453 A PE 2008001453A PE 20090630 A1 PE20090630 A1 PE 20090630A1
- Authority
- PE
- Peru
- Prior art keywords
- carboxi
- indeol
- substitute
- derivatives
- methods
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 241000711549 Hepacivirus C Species 0.000 abstract 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE INDOL 2-CARBOXI SUSTITUIDOS DE FORMULA (I) DONDE R1 ES -[C(R12)2]r-, -[C(R12)2]r-O-[C(R12)2]q-, -[C(R12)2]r-N(R9)-[C(R12)2]q-, ENTRE OTROS; R2 ES -C(O)R9, -C(O)OR9, -C(O)OCH2OR9, ENTRE OTROS, EN DONDE R12 ES H, HALO, -N(R9)2, ENTRE OTROS; R9 ES H, ALQUILO, ALQUENILO, ALQUINILO, ENTRE OTROS; q ES DE 0 A 4; r ES DE 1 A 4; R4, R5, R6 Y R7 SON CADA UNO H, ALQUILO, ALQUENILO, ARILO, ENTRE OTROS; R10 ES H, CICLOALQUILO, ARILO, HETEROARILO, ENTRE OTROS; R3 ES UN COMPUESTO DE FORMULA (i) O (ii), DONDE R30 ES H, ALQUILO, ARILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS LOS DE FORMULA (a), (b), ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DE UNA INFECCION VIRAL POR EL VIRUS DE LA HEPATITIS C (VHC)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96869807P | 2007-08-29 | 2007-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090630A1 true PE20090630A1 (es) | 2009-05-16 |
Family
ID=39968138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008001453A PE20090630A1 (es) | 2007-08-29 | 2008-08-27 | Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion |
Country Status (17)
Country | Link |
---|---|
US (1) | US8614229B2 (es) |
EP (1) | EP2408761B1 (es) |
JP (2) | JP5272008B2 (es) |
KR (1) | KR20100067652A (es) |
CN (1) | CN101821252A (es) |
AR (1) | AR068106A1 (es) |
AU (1) | AU2008295484B2 (es) |
BR (1) | BRPI0815811A2 (es) |
CA (1) | CA2697454C (es) |
CL (1) | CL2008002539A1 (es) |
EC (1) | ECSP10010004A (es) |
ES (1) | ES2447543T3 (es) |
MX (1) | MX2010002317A (es) |
PE (1) | PE20090630A1 (es) |
RU (1) | RU2010111551A (es) |
TW (1) | TW200924780A (es) |
WO (1) | WO2009032124A1 (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110104109A1 (en) * | 2005-07-13 | 2011-05-05 | Frank Bennett | Tetracyclic indole derivatives and their use for treating or preventing viral infections |
CA2674831A1 (en) | 2006-12-22 | 2008-11-13 | Schering Corporation | 5,6-ring annulated indole derivatives and methods of use thereof |
KR20090094154A (ko) | 2006-12-22 | 2009-09-03 | 쉐링 코포레이션 | Hcv 및 관련 바이러스 감염을 치료 또는 예방하기 위한 4,5-환 환상 인돌 유도체 |
AU2007339386B8 (en) | 2006-12-22 | 2013-12-05 | Merck Sharp & Dohme Corp. | 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections |
US8404845B2 (en) * | 2007-08-29 | 2013-03-26 | Merck Sharp & Dohme Corp. | 2,3-substituted azaindole derivatives for treating viral infections |
PE20090630A1 (es) | 2007-08-29 | 2009-05-16 | Schering Corp | Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion |
MX2010005356A (es) * | 2007-11-16 | 2010-05-27 | Schering Corp | Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos. |
MX2010005355A (es) * | 2007-11-16 | 2010-06-02 | Schering Corp | Derivados de indol sustituidos con 3-aminosulfonilo y metodos de uso de los mismos. |
CA2727620A1 (en) * | 2008-06-13 | 2009-12-17 | Schering Corporation | Tricyclic indole derivatives and methods of use thereof |
US8980920B2 (en) | 2009-05-29 | 2015-03-17 | Merck Sharp & Dohme Corp. | Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C |
US20120232062A1 (en) * | 2009-10-20 | 2012-09-13 | Eiger Biopharmaceuticals, Inc. | Azaindazoles to treat flaviviridae virus infection |
BR112012012085A2 (pt) | 2009-11-21 | 2016-05-17 | Hoffmann La Roche | compostos antivirais heterocíclicos |
CA2782024A1 (en) | 2009-11-25 | 2011-06-03 | Schering Corporation | Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases |
US20130156731A1 (en) | 2009-12-22 | 2013-06-20 | Kevin X. Chen | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas |
JP2013522202A (ja) | 2010-03-09 | 2013-06-13 | メルク・シャープ・エンド・ドーム・コーポレイション | 縮合三環式シリル化合物およびウイルス疾患の治療のためのその使用方法 |
BR112013000245A2 (pt) * | 2010-07-07 | 2016-05-24 | Hoffmann La Roche | compostos antivirais heterocíclicos |
JP2013541499A (ja) | 2010-07-26 | 2013-11-14 | メルク・シャープ・エンド・ドーム・コーポレイション | 置換されたビフェニレン化合物およびウイルス性疾患の治療のためのその使用方法 |
WO2012050848A1 (en) | 2010-09-29 | 2012-04-19 | Schering Corporation | Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases |
AU2011320696B2 (en) | 2010-10-26 | 2016-07-21 | Presidio Pharmaceuticals, Inc. | Inhibitors of Hepatitis C Virus |
EP2796456A1 (en) | 2010-12-09 | 2014-10-29 | Amgen Inc. | Bicyclic compounds as Pim inhibitors |
AU2012230890A1 (en) | 2011-03-22 | 2013-09-26 | Amgen Inc. | Azole compounds as Pim inhibitors |
US9156872B2 (en) | 2011-04-13 | 2015-10-13 | Merck Sharp & Dohme Corp. | 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
EP2696681B1 (en) | 2011-04-13 | 2018-10-03 | Merck Sharp & Dohme Corp. | 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
WO2013033901A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases |
WO2013033900A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases |
WO2013033899A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases |
WO2013039876A1 (en) | 2011-09-14 | 2013-03-21 | Merck Sharp & Dohme Corp. | Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
AR092959A1 (es) | 2012-10-17 | 2015-05-06 | Merck Sharp & Dohme | Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales |
WO2014059901A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | 2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases |
WO2014059902A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | 2'-disubstituted substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases |
KR20150086325A (ko) | 2012-11-19 | 2015-07-27 | 머크 샤프 앤드 돔 코포레이션 | 바이러스성 질환을 치료하기 위한 2''-알키닐 치환된 뉴클레오시드 유도체 |
US9394285B2 (en) | 2013-03-15 | 2016-07-19 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
WO2014204831A1 (en) | 2013-06-18 | 2014-12-24 | Merck Sharp & Dohme Corp. | Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
WO2014205592A1 (en) | 2013-06-24 | 2014-12-31 | Merck Sharp & Dohme Corp. | Heterocyclic compounds and methods of use thereof for treatment of hepatitis c |
WO2014205593A1 (en) | 2013-06-24 | 2014-12-31 | Merck Sharp & Dohme Corp. | Substituted benzofuran compounds and methods of use thereof for treatment of viral diseases |
EP3063140A4 (en) | 2013-10-30 | 2017-11-08 | Merck Sharp & Dohme Corp. | Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof |
EA201890152A1 (ru) | 2015-06-26 | 2018-08-31 | Такеда Фармасьютикал Компани Лимитед | Производные 2,3-дигидро-4h-1,3-бензоксазин-4-онов в качестве модуляторов холинергического мускаринового m1 рецептора |
EP3366679B1 (en) | 2015-10-20 | 2021-03-24 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
WO2017223012A1 (en) | 2016-06-20 | 2017-12-28 | Merck Sharp & Dohme Corp. | Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases |
US20220281824A1 (en) * | 2019-07-30 | 2022-09-08 | Oregon State University | Aryl hydrocarbon receptor activators |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE648639C (de) | 1935-05-19 | 1937-08-05 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von Dipyrrolen |
US3632805A (en) * | 1967-12-08 | 1972-01-04 | Sumitomo Chemical Co | Process for producing 1-aminoalkyl-benzodiazepine derivatives |
US3663534A (en) * | 1969-01-25 | 1972-05-16 | Sumitomo Chemical Co | Process for preparing benzodiazepine derivatives and salts thereof |
JPS4945876B1 (es) | 1970-01-29 | 1974-12-06 | ||
US3867372A (en) * | 1970-02-03 | 1975-02-18 | Sumitomo Chemical Co | Benzodiazepine process |
US3910889A (en) | 1970-08-31 | 1975-10-07 | Sumitomo Chemical Co | Novel benzodiazepine derivatives and preparation thereof |
JPS4843359B1 (es) * | 1970-08-31 | 1973-12-18 | ||
JPS494461B1 (es) * | 1970-12-17 | 1974-02-01 | ||
AU575854B2 (en) | 1983-10-04 | 1988-08-11 | Shionogi & Co., Ltd. | 7beta-(carboxyalkenamido) cephalosporins |
US5017380A (en) | 1986-07-02 | 1991-05-21 | Shionogi & Co., Ltd. | Gelatin hard capsule containing crystalline hydrate of oral cephalosporin |
NZ220764A (en) | 1986-07-02 | 1989-09-27 | Shionogi & Co | Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions |
CA2038925A1 (en) | 1990-03-26 | 1991-09-27 | Takashi Sohda | Indole derivatives, their production and use |
JPH04149429A (ja) | 1990-10-12 | 1992-05-22 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー反転写真感光材料およびそれを用いた画像形成方法 |
IT1278077B1 (it) | 1995-05-25 | 1997-11-17 | Angeletti P Ist Richerche Bio | Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal |
US5922757A (en) | 1996-09-30 | 1999-07-13 | The Regents Of The University Of California | Treatment and prevention of hepatic disorders |
ZA979327B (en) | 1996-10-18 | 1998-05-11 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease. |
GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
DE69827956T2 (de) | 1997-08-11 | 2005-04-14 | Boehringer Ingelheim (Canada) Ltd., Laval | Peptidanaloga mit inhibitorischer wirkung auf hepatitis c |
FR2768146B1 (fr) | 1997-09-05 | 2000-05-05 | Oreal | Nouveaux composes de la famille des indole-carboxyliques et leur utilisation |
EP1268525B1 (en) | 2000-04-05 | 2008-12-31 | Schering Corporation | Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
EP1192963A4 (en) | 2000-04-05 | 2004-08-25 | Toray Industries | ADSORBENTS FOR PROTEINS OF THE HIGH MOBILITY PROTEIN AND PILLAR GROUP FOR CLEANING BODY LIQUIDS |
AR030558A1 (es) | 2000-04-19 | 2003-08-27 | Schering Corp | COMPUESTOS MACROCICLICOS, QUE INCLUYEN ENANTIOMEROS, ESTEROISOMEROS, ROTAMEROS Y TAUTOMEROS, SALES Y SOLVATOS FARMACEUTICAMENTE ACEPTABLES, COMPOSICIoN FARMACEUTICA, UN METODO PARA SU PREPARACION Y EL USO DE DICHOS COMPUESTOS PARA LA ELABORACION DE UN MEDICAMENTO, INHIBIDORES DE LA SERINA PROTEASA, |
HU229997B1 (en) | 2000-07-21 | 2015-04-28 | Dendreon Corp San Diego | Peptides as ns3-serine protease inhibitors of hepatitis c virus |
HUP0303358A3 (en) | 2000-07-21 | 2005-10-28 | Schering Corp | Novel peptides as ns3-serine protease inhibitors of hepatitis c virus and pharmaceutical compositions containing them |
AR034127A1 (es) | 2000-07-21 | 2004-02-04 | Schering Corp | Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento |
AR029851A1 (es) | 2000-07-21 | 2003-07-16 | Dendreon Corp | Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c |
US6787651B2 (en) | 2000-10-10 | 2004-09-07 | Smithkline Beecham Corporation | Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
IL155842A0 (en) | 2000-12-12 | 2003-12-23 | Schering Corp | Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
JP2004518658A (ja) | 2000-12-18 | 2004-06-24 | イーライ・リリー・アンド・カンパニー | 新規なsPLA2インヒビター |
ATE378328T1 (de) | 2001-02-22 | 2007-11-15 | Univ London Pharmacy | Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung |
EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
FR2839718B1 (fr) | 2002-05-17 | 2004-06-25 | Sanofi Synthelabo | Derives d'indole, leur procede de preparation et les compositions pharmaceutiques en contenant |
CA2501547A1 (en) | 2002-10-15 | 2004-04-29 | Rigel Pharmaceuticals, Inc. | Substituted indoles and their use as hcv inhibitors |
JP2004149429A (ja) | 2002-10-29 | 2004-05-27 | Takeda Chem Ind Ltd | インドール化合物およびその用途 |
US20050075331A1 (en) | 2003-10-06 | 2005-04-07 | Pratt John K. | Anti-infective agents |
ZA200509718B (en) | 2003-05-30 | 2007-03-28 | Gemin X Biotechnologies Inc | Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
GB0323845D0 (en) * | 2003-10-10 | 2003-11-12 | Angeletti P Ist Richerche Bio | Chemical compounds,compositions and uses |
AR046833A1 (es) | 2003-11-10 | 2005-12-28 | Schering Corp | Anticuerpos anti-interleuquina-10 |
US8067379B2 (en) | 2004-02-27 | 2011-11-29 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
US20070219212A1 (en) | 2004-03-01 | 2007-09-20 | Condon Stephen M | Pyranouidole Derivatives and the Use Thereof for the Treatment of Hepatitis C Virus Infection or Disease |
WO2005107745A1 (en) | 2004-05-06 | 2005-11-17 | Schering Corporation | An inhibitor of hepatitis c |
EP1604988A1 (en) * | 2004-05-18 | 2005-12-14 | Sanofi-Aventis Deutschland GmbH | Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
WO2007084413A2 (en) | 2004-07-14 | 2007-07-26 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
US7153848B2 (en) | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
CA2577413A1 (en) | 2004-09-23 | 2006-03-30 | Wyeth | Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus |
DE102004047272A1 (de) * | 2004-09-24 | 2006-04-06 | Schering Ag | Inhibitoren der löslichen Adenylatzyklase |
JP4149429B2 (ja) | 2004-10-26 | 2008-09-10 | 本田技研工業株式会社 | 車両の走行安全装置 |
EP1807397A2 (en) | 2004-10-26 | 2007-07-18 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Tetracyclic indole derivatives as antiviral agents |
WO2006076529A1 (en) * | 2005-01-14 | 2006-07-20 | Genelabs Technologies, Inc. | Indole derivatives for treating viral infections |
US20110104109A1 (en) | 2005-07-13 | 2011-05-05 | Frank Bennett | Tetracyclic indole derivatives and their use for treating or preventing viral infections |
GB0518390D0 (en) | 2005-09-09 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
JP2009508966A (ja) | 2005-09-23 | 2009-03-05 | シェーリング コーポレイション | 治療薬としての縮合四環性mGluR1アンタゴニスト |
JP2009523732A (ja) | 2006-01-13 | 2009-06-25 | ピーティーシー セラピューティクス,インコーポレーテッド | C型肝炎の治療方法 |
PE20080197A1 (es) | 2006-02-09 | 2008-04-11 | Schering Corp | Combinaciones que involucran el (los) inhibidor (es) de la proteasa del hcv, y metodos de tratamiento relacionado al (los) mismos(s) |
CA2674831A1 (en) * | 2006-12-22 | 2008-11-13 | Schering Corporation | 5,6-ring annulated indole derivatives and methods of use thereof |
KR20090094154A (ko) | 2006-12-22 | 2009-09-03 | 쉐링 코포레이션 | Hcv 및 관련 바이러스 감염을 치료 또는 예방하기 위한 4,5-환 환상 인돌 유도체 |
AU2007339386B8 (en) | 2006-12-22 | 2013-12-05 | Merck Sharp & Dohme Corp. | 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections |
US8404845B2 (en) | 2007-08-29 | 2013-03-26 | Merck Sharp & Dohme Corp. | 2,3-substituted azaindole derivatives for treating viral infections |
PE20090630A1 (es) | 2007-08-29 | 2009-05-16 | Schering Corp | Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion |
EP2197842B1 (en) | 2007-08-29 | 2012-05-23 | Schering Corporation | 2, 3-substituted indole derivatives for treating viral infections |
JP4737166B2 (ja) | 2007-09-07 | 2011-07-27 | 株式会社デンソー | 目詰まり検出装置 |
MX2010005356A (es) | 2007-11-16 | 2010-05-27 | Schering Corp | Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos. |
MX2010005355A (es) | 2007-11-16 | 2010-06-02 | Schering Corp | Derivados de indol sustituidos con 3-aminosulfonilo y metodos de uso de los mismos. |
-
2008
- 2008-08-27 PE PE2008001453A patent/PE20090630A1/es not_active Application Discontinuation
- 2008-08-27 CN CN200880110744A patent/CN101821252A/zh active Pending
- 2008-08-27 RU RU2010111551/04A patent/RU2010111551A/ru unknown
- 2008-08-27 JP JP2010522934A patent/JP5272008B2/ja not_active Expired - Fee Related
- 2008-08-27 WO PCT/US2008/010148 patent/WO2009032124A1/en active Application Filing
- 2008-08-27 ES ES08795629.8T patent/ES2447543T3/es active Active
- 2008-08-27 TW TW097132796A patent/TW200924780A/zh unknown
- 2008-08-27 EP EP08795629.8A patent/EP2408761B1/en active Active
- 2008-08-27 AU AU2008295484A patent/AU2008295484B2/en not_active Ceased
- 2008-08-27 CA CA2697454A patent/CA2697454C/en active Active
- 2008-08-27 BR BRPI0815811-8A2A patent/BRPI0815811A2/pt not_active Application Discontinuation
- 2008-08-27 MX MX2010002317A patent/MX2010002317A/es not_active Application Discontinuation
- 2008-08-27 KR KR1020107006433A patent/KR20100067652A/ko not_active Application Discontinuation
- 2008-08-27 US US12/675,891 patent/US8614229B2/en active Active
- 2008-08-27 AR ARP080103715A patent/AR068106A1/es not_active Application Discontinuation
- 2008-08-28 CL CL2008002539A patent/CL2008002539A1/es unknown
-
2010
- 2010-02-26 EC EC2010010004A patent/ECSP10010004A/es unknown
-
2013
- 2013-03-05 JP JP2013042524A patent/JP2013100375A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ES2447543T3 (es) | 2014-03-12 |
WO2009032124A1 (en) | 2009-03-12 |
JP5272008B2 (ja) | 2013-08-28 |
TW200924780A (en) | 2009-06-16 |
CA2697454A1 (en) | 2009-03-12 |
AR068106A1 (es) | 2009-11-04 |
JP2013100375A (ja) | 2013-05-23 |
AU2008295484A1 (en) | 2009-03-12 |
US8614229B2 (en) | 2013-12-24 |
RU2010111551A (ru) | 2011-10-10 |
EP2408761A1 (en) | 2012-01-25 |
ECSP10010004A (es) | 2010-03-31 |
EP2408761B1 (en) | 2014-01-01 |
JP2010537981A (ja) | 2010-12-09 |
CL2008002539A1 (es) | 2009-07-17 |
MX2010002317A (es) | 2010-03-22 |
CN101821252A (zh) | 2010-09-01 |
US20110104110A1 (en) | 2011-05-05 |
KR20100067652A (ko) | 2010-06-21 |
AU2008295484B2 (en) | 2013-09-26 |
CA2697454C (en) | 2015-11-03 |
BRPI0815811A2 (pt) | 2015-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20090630A1 (es) | Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion | |
PE20090995A1 (es) | Derivados indolicos 2,3-sustituidos como inhibidores del virus de la hepatitis c (vhc) | |
PE20171341A1 (es) | Compuestos de pirazina para el tratamiento de enfermedades infecciosas | |
PE20090994A1 (es) | Derivados de azaindol 2,3-sustituidos como agentes antivirales | |
PE20071326A1 (es) | Inhibidores de la polimerasa viral | |
PE20051150A1 (es) | Compuestos azufrados como inhibidores de la serina proteasa ns3 del virus de la hepatitis c | |
PE20070124A1 (es) | Derivados de heteroaril para tratar virus | |
PE20090042A1 (es) | Analogos de ciclopamina | |
PE20050013A1 (es) | Composiciones farmaceuticas como inhibidores de la proteasa del virus de la hepatitis c | |
AR054214A1 (es) | Compuestos derivados de 1, 1 - dioxotiadiazina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la infeccion por el virus de la hepatitis c. | |
PE20080992A1 (es) | Quinoxalinil macrociclicos inhibidores de serina proteasa del virus de la hepatitis c | |
TW200800949A (en) | Macrocylic inhibitors of hepatitis C virus | |
PE20060381A1 (es) | Analogos de dipeptidos inhibidores de la hepatitis c | |
CO5580815A2 (es) | Derivados de adamantana, procesos para su preparacion y composiciones farmaceuticas que los contienen | |
EA200970478A1 (ru) | Аналоги тиофена для лечения или предупреждения флавивирусных инфекций | |
PE20070804A1 (es) | Compuestos heterociclicos como inhibidores de proteasa aspartica | |
PE20120666A1 (es) | Inhibidores de los virus flaviviridae | |
PE20121479A1 (es) | Inhibidores del virus de la hepatitis c | |
AR054482A1 (es) | Derivados de azetidinona para el tratamiento de hiperlipidemias | |
NO20081074L (no) | Macrocyclisk inhibitorer av hepatitis C-virus | |
CO5590957A2 (es) | Amino-1,3,5-triazinas sustituidas en n con radicales biciclicos quirales, procedimiento para su preparacion, composiciones de las mismas y su uso como herbicidas y reguladores del crecimiento de las plantas | |
AR076274A1 (es) | Inhibidores del virus de la hepatitis c | |
PE20070115A1 (es) | Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas | |
AR023152A1 (es) | Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion | |
ES2640911T3 (es) | Cicloalquilnitrilpirazolcarboxamidas como inhibidores de la quinasa Janus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |